Rocket Lab's Share Price Is Now a Variable in Its Own Merger Math

Rocket Lab shares fell 19.4% over seven sessions as deal structure amplifies regulatory noise; Q2 revenue hit record $234.1M, but net loss missed estimates.

The market's treatment of Rocket Lab this month offers a masterclass in how deal mechanics can hijack a stock's trajectory. The company's shares have fallen for seven consecutive sessions, shedding 19.4 percent and roughly $10 billion in market value, even as the underlying business posts record numbers and the broader market barely flinches.

The proximate cause of the slide is not a profit warning or operational setback. It is a regulatory filing. SpaceX has raised concerns with the Federal Communications Commission about potential spectrum interference from future Starlink gateways involving Iridium. Notably, SpaceX is not opposing Rocket Lab's planned acquisition of Iridium — it is merely requesting closer scrutiny during the license-transfer process. That alone was enough to knock the stock down 6 percent.

A Deal Structure That Amplifies Every Headwind

The outsized reaction stems from the architecture of the roughly $8 billion Iridium transaction. Each Iridium share will convert into $27 in cash plus a variable number of Rocket Lab shares, calculated using the ten-day volume-weighted average price shortly before closing. The implication is straightforward: when Rocket Lab's stock falls, the exchange ratio shifts automatically, meaning any negative news becomes a self-reinforcing drag on the deal's terms.

Market observers suggest relatively few investors have fully grasped this mechanism, which converts regulatory noise into compounding share-price pressure. The story here is less about the news itself than the structure that magnifies it.

Rocket Lab reaffirmed the acquisition timeline on August 10. The US antitrust waiting period expired August 12, SEC registration documents have been filed, and FCC applications for license transfers have been pending since August 10. Iridium shareholders are scheduled to vote on the combination on September 24. Until then, every market-moving headline carries the potential to alter the exchange ratio.

Record Revenue, but the Bottom Line Misses

For all the turbulence, the operational picture remains robust. Second-quarter revenue hit a record $234.1 million, up 62 percent year over year, with the backlog climbing 137 percent to $2.36 billion. The company guided third-quarter revenue to between $250 million and $265 million, with GAAP gross margin of 29 to 31 percent.

The earnings line, however, disappointed. The company posted a net loss of $49.3 million, or 8 cents per share — 2 cents worse than analysts had projected, though an improvement on the $66.4 million loss recorded in the year-ago quarter. Shares fell 7 percent in after-hours trading on that miss, despite the strong top-line growth and full order book.

The stock closed Friday at €55.60, down 4.1 percent on the day and 11 percent over the week. It now trades roughly 18 percent below its 50-day moving average and 58 percent below the 52-week high set in May.

Defense Dollars and Launch Momentum

The defense pipeline, meanwhile, keeps expanding. The US Space Force awarded Rocket Lab a $397 million contract for "flatellites" — flat-built satellites designed for real-time threat tracking under the Golden Dome missile-defense program. Combined with a separate $266 million missile-defense award, those two deals alone total $663 million. The company says its 2026 defense contracts approach $1 billion.

The Space Force also added Rocket Lab to a five-provider data-relay network alongside York Space, Northrop Grumman, Lockheed Martin, and Amazon LEO, part of a push toward multi-vendor architecture. A separate framework agreement worth $981 million covers the NITE-STAR program, with an additional $12 million for a data-network consortium.

On the launch side, Rocket Lab secured a contract for three Electron missions for Japanese radar-imaging firm iQPS, which aims to build a 24-satellite constellation by 2028. That brings the company's contracted Electron launches to 18, seven of which have already flown. The 93rd Electron mission lifted off on August 20. Kepler Communications has also booked the first dedicated Neutron mission, and Viasat selected Rocket Lab for a jam-resistant satellite for security applications.

Neutron Progress and a Cautious Timeline

Development of the Neutron rocket continues apace. On July 13, the company confirmed a successful test of the Archimedes engine that will power the vehicle — nine of them are expected to produce 1.45 million pounds of thrust, with a vacuum variant, AVac, delivering 1.2 times the thrust at 2.5 meters greater height. The latest test simulated space conditions using stub skirts. A prior tank rupture during a pressure test on the main stage was a setback, and CEO Peter Beck has been measured on timing: the company will reach orbit when ready. Neutron's debut is slated for late 2026 or 2027, depending on the source.

Insider Sales, Explained

Several executives, including chief operating officer Frank Klein, sold shares during this period under pre-arranged trading plans to cover tax obligations from equity compensation. The managers retained the majority of their holdings after the sales, and the transactions appear routine.

The broader lesson extends beyond Rocket Lab. As billion-dollar acquisitions increasingly incorporate variable stock components, a company's own share price becomes a playing field for competitors and regulators alike. When SpaceX files a complaint, it influences — through the detour of deal mechanics — the price Rocket Lab ultimately pays for Iridium. That is not a sign of corporate weakness; it is a structural feature of modern merger financing that investors are still learning to price in.